tsr 022
tesaro
[]
heading to hear gerald falchook of report on the phase 1 amber trail at #asco22? get your tim-3 wheels turning with this highly-cited #jitc review: tim-3 finds its place in the cancer immunotherapy landscape 
#JITC is the official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. Editor-in-Chief: Pedro J. Romero, MD.